Tyrosine Kinase Inhibition Alters Intratumoral CD8+ T-cell Subtype Composition and Activity

Andrew Tieniber(University of Pennsylvania), Ronald P. DeMatteo(University of Pennsylvania)
Cancer Immunology Research
August 2, 2022
Cited by 10


Related Papers